Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion

S Maity, D Kar, K De, V Chander… - Journal of …, 2013 - joe.bioscientifica.com
There is a sex difference in the hypothalamo-pituitary-adrenal (HPA) axis of many species,
although there are sparse data on the sheep. In the present study we have compared the …

Sacubitril/valsartan in heart failure and beyond—from molecular mechanisms to clinical relevance

M Nikolic, I Srejovic, J Jovic, J Sretenovic, J Jeremic… - 2022 - scidar.kg.ac.rs
As the ultimate pathophysiological event, heart failure (HF) may arise from various
cardiovascular (CV) conditions, including sustained pressure/volume overload of the left …

N-terminal pro-B–type natriuretic peptide levels in acute versus chronic left ventricular dysfunction

I Fried, B Bar-Oz, Z Perles, AJJT Rein, Z Zonis… - The Journal of …, 2006 - Elsevier
OBJECTIVES: To determine whether acute left ventricular dysfunction (LVD) causes
significantly higher elevation of N-terminal pro-B–type natriuretic peptide (NT-proBNP) …

C-type natriuretic peptide and heart failure

S Del Ry, C Passino, M Emdin, D Giannessi - Pharmacological research, 2006 - Elsevier
C-type natriuretic peptide (CNP) is a peptide produced by the vascular endothelium with
vasodilative properties. It shares structural and physiological properties with the atrial and …

[HTML][HTML] Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor

J Sun, W Xu, H Hua, Y Xiao, X Chen, Z Gao, S Li… - Biomedicine & …, 2020 - Elsevier
Abstract Background and Purpose Angiotensin receptor-NEP inhibitor (ARNi), which
includes an angiotensin receptor blocker (ARB) and a neprilysin inhibitor (NEPi), has been …

Pathophysiologie der chronischen Herzinsuffizienz

J Weil, H Schunkert - Clinical Research in Cardiology, 2006 - search.proquest.com
Die chronische Herzinsuffizienz ist eine fortschreitende Erkrankung, die bei vielen Patienten
zum Tode führt. Veränderungen in der intrazellulären Signaltransduktion sowie in der …

[HTML][HTML] Insulin resistance and altered glucose transporter 4 expression in experimental uremia

D Aksentijević, S Bhandari, AML Seymour - Kidney international, 2009 - Elsevier
Progressive ventricular hypertrophy can lead to the development of insulin resistance, a
feature of both chronic kidney disease and heart failure. Here we induced uremia in adult …

Focus on the novel cardiovascular drug LZC696: from evidence to clinical consideration

LM Lin, Y Wu, MF Wu, JX Lin - Cardiovascular drugs and therapy, 2016 - Springer
Abstract LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor (ARNI), is
comprised of the angiotensin receptor blocker valsartan and the neprilysin inhibitor pro-drug …

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice

F Werner, B Kojonazarov, B Gaßner, M Abeßer… - Basic research in …, 2016 - Springer
The cardiac hormone atrial natriuretic peptide (ANP) regulates systemic and pulmonary
arterial blood pressure by activation of its cyclic GMP-producing guanylyl cyclase-A (GC-A) …

[PDF][PDF] BNP shows myocardial injury earlier than Troponin-I in experimental carbon monoxide poisoning.

M Yücel, L Avsarogullari, P DURUKAN… - European Review for …, 2016 - researchgate.net
OBJECTIVE: In this study, our purpose was to determine whether plasma BNP level can be
useful or not in determining the severity of myocardial injury formed by CO poisoning and to …